Frank Grieger

506 total citations
25 papers, 349 citations indexed

About

Frank Grieger is a scholar working on Neurology, Epidemiology and Cognitive Neuroscience. According to data from OpenAlex, Frank Grieger has authored 25 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Neurology, 9 papers in Epidemiology and 5 papers in Cognitive Neuroscience. Recurrent topics in Frank Grieger's work include Parkinson's Disease Mechanisms and Treatments (18 papers), Restless Legs Syndrome Research (9 papers) and Neurological disorders and treatments (6 papers). Frank Grieger is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (18 papers), Restless Legs Syndrome Research (9 papers) and Neurological disorders and treatments (6 papers). Frank Grieger collaborates with scholars based in Germany, United States and Belgium. Frank Grieger's co-authors include Babak Boroojerdi, Erwin Schollmayer, Mahnaz Asgharnejad, Cornelia Thiels, Michael Linden, Lars Bauer, Daniel Weintraub, К. Ray Chaudhuri, Angelo Antonini and Werner Cassel and has published in prestigious journals such as PLoS ONE, Neurology and Sleep Medicine.

In The Last Decade

Frank Grieger

24 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Frank Grieger Germany	12	208	124	100	32	29	25	349
Jennaya Christensen Australia	11	144 0.7×	102 0.8×	53 0.5×	27 0.8×	26 0.9×	19	409
Luisa Sestito Italy	9	51 0.2×	128 1.0×	61 0.6×	34 1.1×	24 0.8×	16	392
James W. Bales United States	11	318 1.5×	262 2.1×	64 0.6×	9 0.3×	13 0.4×	16	495
Reinhard Ehret Germany	10	366 1.8×	53 0.4×	49 0.5×	12 0.4×	18 0.6×	18	443
Deborah Shear United States	11	140 0.7×	92 0.7×	19 0.2×	40 1.3×	47 1.6×	26	353
B. Hock Germany	6	142 0.7×	229 1.8×	162 1.6×	7 0.2×	17 0.6×	6	376
Michal Minár Slovakia	10	291 1.4×	114 0.9×	47 0.5×	8 0.3×	8 0.3×	35	398
Victoria Larsson Sweden	8	145 0.7×	33 0.3×	54 0.5×	11 0.3×	30 1.0×	13	310
Richard Mindham United Kingdom	6	398 1.9×	65 0.5×	81 0.8×	8 0.3×	17 0.6×	14	533
Pettarusp M. Wadia India	9	366 1.8×	38 0.3×	105 1.1×	21 0.7×	29 1.0×	15	528

Countries citing papers authored by Frank Grieger

Since Specialization

Citations

This map shows the geographic impact of Frank Grieger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frank Grieger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frank Grieger more than expected).

Fields of papers citing papers by Frank Grieger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frank Grieger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frank Grieger. The network helps show where Frank Grieger may publish in the future.

Co-authorship network of co-authors of Frank Grieger

This figure shows the co-authorship network connecting the top 25 collaborators of Frank Grieger. A scholar is included among the top collaborators of Frank Grieger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frank Grieger. Frank Grieger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schindler, Thomas M., et al.. (2020). Patient preferences when searching for clinical trials and adherence of study records to ClinicalTrials.gov guidance in key registry data fields. PLoS ONE. 15(5). e0233294–e0233294. 6 indexed citations

Müller, Thomas, Eduardo Tolosa, Mahnaz Asgharnejad, et al.. (2018). An observational study of rotigotine transdermal patch and other currently prescribed therapies in patients with Parkinson’s disease. Journal of Neural Transmission. 125(6). 953–963. 14 indexed citations

Lawall, Holger, et al.. (2017). Efficacy and Safety of Alprostadil in Patients with Peripheral Arterial Occlusive Disease Fontaine Stage IV: Results of a Placebo Controlled Randomised Multicentre Trial (ESPECIAL). European Journal of Vascular and Endovascular Surgery. 53(4). 559–566. 24 indexed citations

Giladi, Nir, Mahnaz Asgharnejad, Lars Bauer, Frank Grieger, & Babak Boroojerdi. (2016). Rotigotine in Combination with the MAO-B Inhibitor Selegiline in Early Parkinson’s Disease: A Post Hoc Analysis. Journal of Parkinson s Disease. 6(2). 401–411. 8 indexed citations

LeWitt, Peter A., Werner Poewe, Lawrence Elmer, et al.. (2016). The Efficacy Profile of Rotigotine During the Waking Hours in Patients With Advanced Parkinson's Disease. Clinical Neuropharmacology. 39(2). 88–93. 3 indexed citations

García‐Borreguero, Diego, Richard P. Allen, Elisabeth Dohin, et al.. (2015). Effects of rotigotine on daytime symptoms in patients with primary restless legs syndrome: a randomized, placebo-controlled study. Current Medical Research and Opinion. 32(1). 77–85. 13 indexed citations

Sieb, Jörn Peter, Tobias Warnecke, Thomas Lauterbach, et al.. (2015). Caregivers’ and physicians’ attitudes to rotigotine transdermal patch versus oral Parkinson’s disease medication: an observational study. Current Medical Research and Opinion. 31(5). 967–974. 10 indexed citations

Cassel, Werner, Karl Kesper, Axel Bauer, et al.. (2015). Significant association between systolic and diastolic blood pressure elevations and periodic limb movements in patients with idiopathic restless legs syndrome. Sleep Medicine. 17. 109–120. 41 indexed citations

Antonini, Angelo, Mahnaz Asgharnejad, Lars Bauer, Frank Grieger, & Babak Boroojerdi. (2015). Incidence of Impulsive and Compulsive Behavior Type Adverse Events with Long-term Rotigotine: A Post-hoc Analysis (I3-5E). Neurology. 84(14_supplement). 1 indexed citations

10.

Oertel, Wolfgang H., Axel Bauer, Werner Cassel, et al.. (2014). Effect Of Rotigotine Transdermal System On Nocturnal Blood Pressure Changes Associated With Periodic Limb Movements During Sleep In Patients With Restless Legs Syndrome (P5.268). Neurology. 82(10_supplement). 1 indexed citations

11.

Woitalla, Dirk, Jan Kassubek, Lars Timmermann, et al.. (2014). Reduction of gastrointestinal symptoms in Parkinson's disease after a switch from oral therapy to rotigotine transdermal patch: A non-interventional prospective multicenter trial. Parkinsonism & Related Disorders. 21(3). 199–204. 24 indexed citations

12.

Augustin, Albert J., et al.. (2013). Alprostadil infusion in patients with dry age related macular degeneration: a randomized controlled clinical trial. Expert Opinion on Investigational Drugs. 22(7). 803–812. 18 indexed citations

13.

Woitalla, Dirk, Thomas Lauterbach, Reinhard Berkels, et al.. (2013). Non-Interventional Study of the Switch from Oral Treatment to Rotigotine Transdermal System in Patients with Parkinson's Disease and Gastrointestinal Symptoms (P01.067). Neurology. 80(7_supplement).

14.

Stiasny‐Kolster, Karin, Daniela Berg, Werner Hofmann, et al.. (2013). Effectiveness and tolerability of rotigotine transdermal patch for the treatment of restless legs syndrome in a routine clinical practice setting in Germany. Sleep Medicine. 14(6). 475–481. 11 indexed citations

15.

Allen, Richard P., Wolfgang H. Oertel, Arthur S. Walters, et al.. (2013). Relation of the International Restless Legs Syndrome Study Group rating scale with the Clinical Global Impression severity scale, the restless legs syndrome 6-item questionnaire, and the restless legs syndrome-quality of life questionnaire. Sleep Medicine. 14(12). 1375–1380. 22 indexed citations

16.

Ondo, William G., Thomas Roth, Frank Grieger, Kimberly Moran, & Ralf Kohnen. (2013). Minimal Clinically Important Improvement in IRLS Total Score in Patients with Restless Legs Syndrome: A Post Hoc Analysis from a 6-Month Placebo-Controlled US-Based Study with Rotigotine Transdermal System (P02.059). Neurology. 80(7_supplement). 2 indexed citations

17.

Oertel, Wolfgang H., Peter A. LeWitt, Nir Giladi, et al.. (2012). Treatment of patients with early and advanced Parkinson's disease with rotigotine transdermal system: Age-relationship to safety and tolerability. Parkinsonism & Related Disorders. 19(1). 37–42. 27 indexed citations

18.

Kim, Han‐Joon, Beom S. Jeon, Won Yong Lee, et al.. (2011). Overnight switch from ropinirole to transdermal rotigotine patch in patients with Parkinson disease. BMC Neurology. 11(1). 100–100. 16 indexed citations

19.

Thürmann, Petra, et al.. (2006). Pharmacokinetics and safety of a novel anti-HBs-enriched immunoglobulin in healthy volunteers after subcutaneous and intramuscular administration. European Journal of Clinical Pharmacology. 62(7). 511–512. 6 indexed citations

20.

Thiels, Cornelia, et al.. (2004). Gender differences in routine treatment of depressed outpatients with the selective serotonin reuptake inhibitor sertraline. International Clinical Psychopharmacology. 20(1). 1–7. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact